Mesothelioma Science News
San Pedro, CA - July 23,
2008
|
1.
|
Pemetrexed plus gemcitabine as first-line chemotherapy
for patients with peritoneal mesothelioma: final report
of a phase II trial
Click here
|
|
|
|
|
2.
|
Prevalence and pattern of lymph node metastasis in
malignant pleural mesothelioma
Click here
|
|
|
|
|
3.
|
A phase II trial of tetrathiomolybdate after surgery
for malignant mesothelioma: final results
Click here
|
|
|
|
|
4.
|
Assessment of biomarkers in asbestos-exposed workers as
indicators of cancer risk
Click here
|
|
|
|
|
5.
|
Orally ingested chrysotile asbestos affects rat lungs
and pleura
Click here
|
|
|
|
|
6.
|
Long-term mortality from pleural and peritoneal cancer
after exposure to asbestos: Possible role of asbestos
clearance
Click here
|
|
|
|
|
7.
|
Evaluation of public and worker exposure due to
naturally occurring asbestos in gravel discovered
during a road construction project
Click here
|
|
|
|
|
8.
|
mTOR Mediates Survival Signals in Malignant
Mesothelioma Grown as Tumor Fragment Spheroids
Click here
|
|
|
|
|
9.
|
Mammalian target of rapamycin contributes to the
acquired apoptotic resistance of human mesothelioma
multicellular spheroids
Click here
|
|
|
|
|
10.
|
Targeted drug delivery to mesothelioma cells using
functionally selected internalizing human single-chain
antibodies
Click here
|
|